Cellectar Inc., a Madison pharmaceutical company working on cancer-fighting drugs, has merged with a publicly traded Boston-area firm, Novelos Therapeutics Inc. The transaction essentially grafts Cellectar’s research onto the upper management of Novelos. Read full Journal Sentinel story here.
Madison drug company Cellectar to merge with Boston’s Novelos
by Tech Council | Apr 12, 2011 | Featured, NEWSROOM, Tech Council News